Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cilnidipine (Primary) ; Imidapril (Primary) ; Candesartan cilexetil
- Indications Hypertension
- Focus Adverse reactions
- 03 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
- 25 Jun 2009 Planned initiation date changed from 1 May 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.
- 07 May 2009 New trial record